MIT Professor’s Moderna Stake on Brink of Topping $1 Billion

Another early investor of Moderna Inc. is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine.

The value of board member Bob Langer’s 3.2%…